halothane has been researched along with sirolimus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Badenhorst, ME; Brooksbank, RL; Isaacs, H; Savage, N | 1 |
| Chini, EN; Walker, H | 1 |
3 other study(ies) available for halothane and sirolimus
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Treatment of normal skeletal muscle with FK506 or rapamycin results in halothane-induced muscle contracture.
Topics: Adolescent; Adult; Anesthetics, Inhalation; Calcium; Carrier Proteins; Child; Child, Preschool; DNA-Binding Proteins; Halothane; Heat-Shock Proteins; Humans; Immunosuppressive Agents; In Vitro Techniques; Malignant Hyperthermia; Middle Aged; Muscle Contraction; Muscle, Skeletal; Polyenes; Ryanodine Receptor Calcium Release Channel; Sirolimus; Tacrolimus; Tacrolimus Binding Proteins | 1998 |
FK506 (tacrolimus) increases halothane-induced Ca2+ release from skeletal muscle sarcoplasmic reticulum.
Topics: Anesthetics, Inhalation; Animals; Calcium; Drug Synergism; Halothane; Immunophilins; Immunosuppressive Agents; Muscle Contraction; Rabbits; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sirolimus; Tacrolimus; Tacrolimus Binding Proteins | 2000 |